Two years of growth hormone treatment in adults with prader-willi syndrome do not improve the low BMD

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages

  Jorgensen A P ^a   Ueland, T ^b   Sode Carlsen, R ^c   Schreiner, T ^a   Rabben, K F ^d   Farholt, S ^c   Hoybye C ^e   Christiansen, J S ^c   Bollerslev, J ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d Frambu ^*  (Norway)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PLACEBO; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE MASS; BONE TURNOVER; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GONAD; HIP; HUMAN; LUMBAR SPINE; MALE; OSTEOLYSIS; OUTCOME ASSESSMENT; PRADER WILLI SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SEX DIFFERENCE; TREATMENT DURATION; Z SCORE;

ABSORPTIOMETRY, PHOTON; ADULT; BONE DENSITY; COHORT STUDIES; DENMARK; FEMALE; HUMAN GROWTH HORMONE; HUMANS; LUMBAR VERTEBRAE; MALE; NORWAY; PLACEBOS; PRADER-WILLI SYNDROME; TIME FACTORS; YOUNG ADULT;

EID: 84876214250     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3378     Document Type: Article

References (45)

1. Burman P, Ritzen EM, Lindgren AC Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev. 2001; 22:787-799.
2. Goldstone AP. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab. 2004; 15:12-20.
3. Whittington JE, Butler JV, Holland AJ Changing rates of genetic subtypes of Prader-Willi syndrome in the UK. Eur J Hum Genet. 2007; 15:127-130.
4. Brambilla P, Bosio L, Manzoni P., Pietrobelli A, Beccaria L, Chiu-mello G. Peculiar body composition in patients with Prader-Lab-hart-Willi syndrome. Am J Clin Nutr. 1997; 65:1369-1374.
5. Goldstone AP, Thomas EL, Brynes A.E., et al Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab. 2001; 86:4330-4338.
6. Hoybye C, Hilding A, Jacobsson H., Thoren M. Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity. J Clin Endocrinol Metab. 2002; 87:3590-3597.
7. Theodoro MF, Talebizadeh Z, Butler MG Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity. Obesity (Silver Spring). 2006; 14:1685-1690.
8. Butler MG, Theodoro MF, Bittel D.C., Donnelly JE Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet A. 2007; 143:449-459.
9. Goldstone AP, Brynes AE, Thomas E.L., et al Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. Am J Clin Nutr. 2002; 75:468-475.
10. de Lind van Wijngaarden RF, Festen DA, Otten BJ, et al. Bone mineral density and effects of growth hormone treatment in prepu-bertal children with Prader-Willi syndrome: a randomized controlled trial. J Clin Endocrinol Metab. 2009; 94:3763-3771.
11. Colmenares A, Pinto G, Taupin P., et al Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome. Horm Res Paediatr. 2010; 75(2):123-130.
12. Angulo M, Castro-Magana M, Mazur B., Canas JA, Vitollo PM, Sarrantonio M. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab. 1996; 9: 393-400.
13. Angulo MA, Castro-Magana M, Lamerson M., Arguello R, Accacha S, Khan A. Final adult heightinchildren with Prader-Willi syndrome with and without human growth hormone treatment. Am J Med Genet A. 2007; 143A:1456-1461.
14. Lindgren AC, Lindberg A. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database). Horm Res. 2008; 70:182-187.
15. Butler JV, Whittington JE, Holland A.J., Boer H., Clarke D, Webb T. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol. 2002; 44:248-255.
16. Kroonen LT, Herman M, Pizzutillo P.D., Macewen GD Prader-Willi syndrome: clinical concerns for the orthopaedic surgeon. J Pediatr Orthop. 2006; 26:673-679.
17. Sinnema M, Maaskant MA, van Schrojenstein Lantman-de Valk HM, et al. Physical health problems in adults with Prader-Willi syndrome. Am J Med Genet A. 2011; 155:2112-2124.
18. Vestergaard P, Kristensen K, Bruun J.M., et al Reduced bonemineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index-a cross-sectional study. J Pediatr. 2004; 144:614-619.
19. Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev. 2008; 29:535-559.
20. Hoybye C. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment. Growth Horm IGF Res. 2004; 14:1-15.
21. Sode-Carlsen R., Farholt S, Rabben K.F., et al Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome. Growth Horm IGF Res. 2010; 20:179-184.
22. Sode-Carlsen R., Farholt S, Rabben K.F., et al One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2010; 95:4943-4950.
23. Corneli G, di Somma C, Baldelli R, et al The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol. 2005; 153:257-264.
24. Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res. 1992; 7:137-145.
25. Kroger H, Vainio P, Nieminen J., Kotaniemi A. Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone. 1995; 17:157-159.
26. Frystyk J, Dinesen B, Orskov H. Non-competitive time-resolved immunofluorometric assays for determination of human insulinlike growth factor I and II. Growth Regul. 1995; 5:169-176.
27. Sode-Carlsen R., Farholt S, Rabben K.F., et al Growthhormonetreat-ment for two years is safe and effective in adults with Prader-Willi syndrome. Growth Horm IGF Res. 2011; 21:185-190.
28. Hoiberg M, Nielsen TL, Wraae K, et al Population-based reference values for bone mineral density in young men. Osteoporos Int. 2007; 18:1507-1514.
29. Gjesdal CG, Aanderud SJ, Haga H.J., Brun JG, Tell GS Femoral and whole-body bone mineral density in middle-aged and older Norwegian men and women: suitability of the reference values. Osteoporos Int. 2004; 15:525-534.
30. Genant HK, Grampp S, Gluer C.C., et al Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res. 1994; 9:1503-1514.
31. Saggese G, Bertelloni S, Baroncelli GI Sex steroids and the acquisition of bone mass. Horm Res. 1997; 48(SUPPL. 5):65-71.
32. Elbornsson M, Gotherstrom G, Bosaeus I., Bengtsson BA, Johanns-son G, Svensson J. Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency. Eur J Endocrinol. 2012; 166:787-795.
33. Jorgensen AP, Fougner KJ, Ueland T, et al Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency. Growth Horm IGF Res. 2011; 21:69-75.
34. Schaller S, Henriksen K, Hoegh-Andersen P, et al In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how bio-markers can assist? Assay Drug Dev Technol. 2005; 3:553-580.
35. Siemensma EP, van Alfen-van der Velden AA, Otten BJ, Laven JS, Hokken-Koelega AC. Ovarian Function and reproductive hormone levels in girls with Prader-Willi syndrome: a longitudinal study. J Clin Endocrinol Metab. 2012; 97(9):E1766-E1773.
36. Siemensma EP, de Lind van Wijngaarden RF, Otten BJ, de Jong FH, Hokken-Koelega AC. Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones. J Clin Endocrinol Metab. 2012; 97:E452-E459.
37. Katzman DK, Bachrach LK, Carter D.R., Marcus R. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab. 1991; 73:1332-1339.
38. Vatanparast H, Bailey DA, Baxter-Jones AD, Whiting SJ Calcium requirements for bone growth in Canadian boys and girls during adolescence. Br J Nutr. 2010; 103:575-580.
39. Borer KT. Physical activity in the prevention and amelioration of osteoporosis in women: interaction of mechanical, hormonal and dietary factors. Sports Med. 2005; 35:779-830.
40. Patel R, Blake GM, Herd R.J., Fogelman I. The effect of weight change on DXA scans in a 2-year trial of etidronate therapy. Calcif Tissue Int. 1997; 61:393-399.
41. Bolotin HH. DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling. Bone. 2007; 41:138-154.
42. Brzozowska MM, Sainsbury A, Eisman J.A., Baldock PA, Center JR Bariatric surgery, bone loss, obesity and possible mechanisms. Obes Rev. 2013; 14(1):52-67.
43. Jager PL, Jonkman S, Koolhaas W., Stiekema A, Wolffenbuttel BH, Slart RH Combined vertebral fracture assessment and bone mineral density measurement: a new standard in the diagnosis of osteoporosis in academic populations. Osteoporos Int. 2011; 22:1059-1068.
44. Eriksen L, Gronbaek M, Helge J.W., Tolstrup JS, Curtis T. The Danish Health Examination Survey 2007-2008 (DANHES 2007-2008). Scand J Public Health. 2011; 39:203-211.
45. Juliusson PB, Roelants M, Eide G.E., et al [Growth references for Norwegian children]. Tidsskr Nor Laegeforen. 2009; 129:281-286.